Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease

  • Carvajal, Silvia
  • Perramón, Meritxell|||0000-0002-1944-8337
  • Oró, Denise
  • Casals, Eudald|||0000-0002-2900-7295
  • Fernández-Varo, Guillermo|||0000-0002-7776-3300
  • Parra-Robert, Marina
  • González de la Presa, Bernardino
  • Ribera, Jordi|||0000-0002-0288-4220
  • Pastor, Oscar|||0000-0002-4368-433X
  • Morales Ruiz, Manuel|||0000-0002-9074-2272
  • Puntes, Víctor|||0000-0001-8996-9499
  • Jiménez, Wladimiro|||0000-0002-9376-0214
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, ranging from steatosis to non-alcoholic steatohepatitis (NASH). Recently, cerium oxide nanoparticles (CeO₂NPs) have emerged as a new antioxidant agent with hepatoprotective properties in experimental liver disease. The aim of the current investigation was to elucidate whether CeO₂NPs display beneficial effects in an experimental model of NAFLD.Therefore, fifteen Wistar rats were subjected to a methionine and choline deficient diet (MCDD) for 6 weeks and intravenously treated with CeO₂NPs or vehicle during the weeks three and four of the diet. The effect of CeO₂NPs on serum biochemistry, hepatic steatosis, inflammation, fatty acid content and expression of reactive oxygen species (ROS) and lipid metabolism related genes was assessed. MCDD fed rats showed increased inflammation, enhanced hepatic lipid accumulation of both saturated and unsaturated fatty acids (FAs) and overexpression of genes related to fatty liver and ROS metabolism. Treatment with CeONPs was able to reduce the size and content of hepatocyte lipid droplets, the hepatic concentration of triglyceride- and cholesterol ester-derived FAs and the expression of several genes involved in cytokine, adipokine and chemokine signaling pathways. These findings suggest that CeO₂NPs could be of beneficial value in NAFLD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cerium oxide nanoparticles protect against oxidant injury and interfere with oxidative mediated kinase signaling in human-derived hepatocytes

  • Carvajal, Silvia
  • Perramón, Meritxell|||0000-0002-1944-8337
  • Casals, Gregori|||0000-0002-3271-1371
  • Oró, Denise
  • Ribera, Jordi|||0000-0002-0288-4220
  • Morales Ruiz, Manuel|||0000-0002-9074-2272
  • Casals, Eudald|||0000-0002-2900-7295
  • Casado, Pedro|||0000-0002-4207-9349
  • Melgar Lesmes, Pedro
  • Fernández-Varo, Guillermo|||0000-0002-7776-3300
  • Cutillas, Pedro
  • Puntes, Víctor|||0000-0001-8996-9499
  • Jiménez, Wladimiro|||0000-0002-9376-0214
Cerium oxide nanoparticles (CeO NPs) possess powerful antioxidant properties, thus emerging as a potential therapeutic tool in non-alcoholic fatty liver disease (NAFLD) progression, which is characterized by a high presence of reactive oxygen species (ROS). The aim of this study was to elucidate whether CeO NPs can prevent or attenuate oxidant injury in the hepatic human cell line HepG2 and to investigate the mechanisms involved in this phenomenon. The effect of CeO NPs on cell viability and ROS scavenging was determined, the differential expression of pro-inflammatory and oxidative stress-related genes was analyzed, and a proteomic analysis was performed to assess the impact of CeO NPs on cell phosphorylation in human hepatic cells under oxidative stress conditions. CeO NPs did not modify HepG2 cell viability in basal conditions but reduced H O-and lipopolysaccharide (LPS)-induced cell death and prevented H O-induced overexpression of MPO, PTGS1 and iNOS. Phosphoproteomic analysis showed that CeO NPs reverted the H O-mediated increase in the phosphorylation of peptides related to cellular proliferation, stress response, and gene transcription regulation, and interfered with H O effects on mTOR, MAPK/ERK, CK2A1 and PKACA signaling pathways. In conclusion, CeO NPs protect HepG2 cells from cell-induced oxidative damage, reducing ROS generation and inflammatory gene expression as well as regulation of kinase-driven cell survival pathways.